Orthopediatrics Corp Stock Analysis
KIDS Stock | USD 24.97 0.57 2.23% |
Orthopediatrics Corp is undervalued with Real Value of 29.93 and Target Price of 40.17. The main objective of Orthopediatrics Corp stock analysis is to determine its intrinsic value, which is an estimate of what Orthopediatrics Corp is worth, separate from its market price. There are two main types of Orthopediatrics Corp's stock analysis: fundamental analysis and technical analysis.
The Orthopediatrics Corp stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Orthopediatrics Corp is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Orthopediatrics Stock trading window is adjusted to America/New York timezone.
Orthopediatrics |
Orthopediatrics Stock Analysis Notes
About 32.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.71. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Orthopediatrics Corp recorded a loss per share of 1.64. The entity had not issued any dividends in recent years. OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana. OrthoPediatrics Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 133 people. To find out more about Orthopediatrics Corp contact Mark Throdahl at 574 268 6379 or learn more at https://www.orthopediatrics.com.Orthopediatrics Corp Quarterly Total Revenue |
|
Orthopediatrics Corp Investment Alerts
The company reported the previous year's revenue of 204.73 M. Net Loss for the year was (37.82 M) with profit before overhead, payroll, taxes, and interest of 148.6 M. | |
Orthopediatrics Corp currently holds about 51.16 M in cash with (27.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.52. | |
Orthopediatrics Corp has a frail financial position based on the latest SEC disclosures | |
Roughly 71.0% of the company shares are owned by institutional investors | |
Latest headline from huffpost.com: 5 Things To Stop Saying To A Child With ADHD |
Orthopediatrics Corp Upcoming and Recent Events
27th of February 2024 Upcoming Quarterly Report | View | |
6th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
27th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Orthopediatrics Largest EPS Surprises
Earnings surprises can significantly impact Orthopediatrics Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2023-11-06 | 2023-09-30 | -0.23 | -0.2 | 0.03 | 13 | ||
2025-03-04 | 2024-12-31 | -0.2567 | -0.29 | -0.0333 | 12 | ||
2019-05-08 | 2019-03-31 | -0.17 | -0.21 | -0.04 | 23 |
Orthopediatrics Corp Environmental, Social, and Governance (ESG) Scores
Orthopediatrics Corp's ESG score is a quantitative measure that evaluates Orthopediatrics Corp's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Orthopediatrics Corp's operations that may have significant financial implications and affect Orthopediatrics Corp's stock price as well as guide investors towards more socially responsible investments.
Orthopediatrics Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | New York State Common Retirement Fund | 2024-12-31 | 450.2 K | State Street Corp | 2024-12-31 | 443.9 K | Millennium Management Llc | 2024-12-31 | 422.7 K | Geode Capital Management, Llc | 2024-12-31 | 392.3 K | Riverbridge Partners Llc | 2024-12-31 | 390.8 K | Point72 Asset Management, L.p. | 2024-12-31 | 321.4 K | Harbor Capital Advisors Inc | 2024-12-31 | 251.6 K | Kennedy Capital Management Inc | 2024-12-31 | 250 K | Portolan Capital Management, Llc | 2024-12-31 | 205.4 K | Brown Capital Management, Llc | 2024-12-31 | 1.9 M | Brown Advisory Holdings Inc | 2024-12-31 | 1.5 M |
Orthopediatrics Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 606.44 M.Orthopediatrics Profitablity
The company has Profit Margin (PM) of (0.18) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.16) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.16.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.12) | (0.13) | |
Return On Capital Employed | (0.07) | (0.07) | |
Return On Assets | (0.08) | (0.08) | |
Return On Equity | (0.11) | (0.11) |
Management Efficiency
Orthopediatrics Corp has return on total asset (ROA) of (0.0405) % which means that it has lost $0.0405 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1034) %, meaning that it created substantial loss on money invested by shareholders. Orthopediatrics Corp's management efficiency ratios could be used to measure how well Orthopediatrics Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.13 in 2025. Return On Capital Employed is likely to drop to -0.07 in 2025. At this time, Orthopediatrics Corp's Net Tangible Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 247.8 M in 2025, whereas Total Current Assets are likely to drop slightly above 134.8 M in 2025.Last Reported | Projected for Next Year | ||
Book Value Per Share | 15.36 | 7.70 | |
Tangible Book Value Per Share | 8.51 | 4.69 | |
Enterprise Value Over EBITDA | (49.35) | (51.81) | |
Price Book Value Ratio | 1.51 | 1.43 | |
Enterprise Value Multiple | (49.35) | (51.81) | |
Price Fair Value | 1.51 | 1.43 | |
Enterprise Value | 515.2 M | 381.9 M |
Management at Orthopediatrics Corp focuses on leveraging technology and optimizing operations. We evaluate the impact of these focuses on the company's financial health and stock performance.
Technical Drivers
As of the 23rd of March, Orthopediatrics Corp holds the Risk Adjusted Performance of 0.0771, semi deviation of 1.95, and Coefficient Of Variation of 1262.18. Orthopediatrics Corp technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices. Please check Orthopediatrics Corp information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Orthopediatrics Corp is priced some-what accurately, providing market reflects its current price of 24.97 per share. Given that Orthopediatrics Corp has jensen alpha of 0.2738, we recommend you to check out Orthopediatrics Corp's recent market performance to make sure the company can sustain itself at a future point.Orthopediatrics Corp Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Orthopediatrics Corp middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Orthopediatrics Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Orthopediatrics Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Orthopediatrics Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Orthopediatrics Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Orthopediatrics Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Orthopediatrics Corp Outstanding Bonds
Orthopediatrics Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Orthopediatrics Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Orthopediatrics bonds can be classified according to their maturity, which is the date when Orthopediatrics Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
AerCap Global Aviation Corp BondUS00773HAA59 | View |
Orthopediatrics Corp Predictive Daily Indicators
Orthopediatrics Corp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Orthopediatrics Corp stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Orthopediatrics Corp Corporate Filings
F4 | 18th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 6th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10K | 5th of March 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
8K | 4th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
14th of February 2025 Other Reports | ViewVerify | |
8K | 14th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 13th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 30th of December 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Orthopediatrics Corp Forecast Models
Orthopediatrics Corp's time-series forecasting models are one of many Orthopediatrics Corp's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Orthopediatrics Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Orthopediatrics Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Orthopediatrics Corp prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Orthopediatrics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Orthopediatrics Corp. By using and applying Orthopediatrics Stock analysis, traders can create a robust methodology for identifying Orthopediatrics entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.20) | (0.22) | |
Operating Profit Margin | (0.14) | (0.15) | |
Net Loss | (0.18) | (0.19) | |
Gross Profit Margin | 0.73 | 0.59 |
Current Orthopediatrics Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Orthopediatrics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Orthopediatrics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
40.17 | Strong Buy | 6 | Odds |
Most Orthopediatrics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Orthopediatrics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Orthopediatrics Corp, talking to its executives and customers, or listening to Orthopediatrics conference calls.
Orthopediatrics Stock Analysis Indicators
Orthopediatrics Corp stock analysis indicators help investors evaluate how Orthopediatrics Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Orthopediatrics Corp shares will generate the highest return on investment. By understating and applying Orthopediatrics Corp stock analysis, traders can identify Orthopediatrics Corp position entry and exit signals to maximize returns.
Begin Period Cash Flow | 33 M | |
Total Stockholder Equity | 354.6 M | |
Property Plant And Equipment Net | 50.6 M | |
Cash And Short Term Investments | 68.8 M | |
Net Invested Capital | 427.7 M | |
Cash | 43.8 M | |
50 Day M A | 24.7858 | |
Net Interest Income | -2.6 M | |
Total Current Liabilities | 34 M | |
Investments | -13.2 M | |
Interest Expense | 2.6 M | |
Stock Based Compensation | 13.5 M | |
Long Term Debt | 73 M | |
Common Stock Shares Outstanding | 23.1 M | |
Tax Provision | -4.1 M | |
Free Cash Flow | -41.3 M | |
Other Current Assets | 9 M | |
Accounts Payable | 8.9 M | |
Net Debt | -19.7 M | |
Depreciation | 19.1 M | |
Other Operating Expenses | 234.2 M | |
Non Current Assets Total | 236 M | |
Liabilities And Stockholders Equity | 473.2 M | |
Non Currrent Assets Other | 27.2 M |
Additional Tools for Orthopediatrics Stock Analysis
When running Orthopediatrics Corp's price analysis, check to measure Orthopediatrics Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthopediatrics Corp is operating at the current time. Most of Orthopediatrics Corp's value examination focuses on studying past and present price action to predict the probability of Orthopediatrics Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthopediatrics Corp's price. Additionally, you may evaluate how the addition of Orthopediatrics Corp to your portfolios can decrease your overall portfolio volatility.